Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1Phase 1/2 1

Status

Recruiting 3Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Neoplasms 4Depression 3Anxiety Disorders 3Neoplasm Metastasis 2Hospice 1Hematologic Neoplasms 1

Interventions

Therapeutics 9Psychiatric Rehabilitation 9Music Therapy 8Cognitive Behavioral Therapy 7Mindfulness 6Surveys and Questionnaires 5Counseling 5Acupuncture Therapy 5Standard of Care 4Mindfulness-Based Stress Reduction 4Methods 4Imagery, Psychotherapy 4Early Intervention, Educational 4Autogenic Training 4Art Therapy 4Therapeutic Touch 3Psychosocial Intervention 3Psilocybin 3Mindfulness-Based Cognitive Therapy 3Massage 3Hypnosis 3Exercise 3Control Groups 3Aromatherapy 3Acceptance and Commitment Therapy 3Yoga 2Touch 2Observation 2Niacin 2Gabapentin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Anxiety Disorders × Psilocybin × Clear all
NCT00302744 2025-03-13

Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety

Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Phase 1/2 Completed
12 enrolled

Anxiety Disorders, Depression, Neoplasms

NCT00957359 2020-10-20

Psilocybin Cancer Anxiety Study

NYU Langone Health

Phase EARLY_PHASE1 Completed
29 enrolled 59 charts

Anxiety Disorders, Depression, Neoplasms

NCT00465595 2018-07-19

Psychopharmacology of Psilocybin in Cancer Patients

Johns Hopkins University

Phase 2 Completed
56 enrolled 8 charts

Anxiety Disorders, Depression, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡